Bio

Nicholas Moore is an adept corporate lawyer with 20 years’ experience advising clients on mergers and acquisitions (M&A), investments, joint ventures, and corporate restructurings. Nick focuses his practice on the life sciences and technology sectors. Nick is especially skilled with cross-border transactions, and prior to joining Morgan Lewis spent six years working in the overseas office of a leading UK firm where he advised on complex transactions across Eastern Europe and Asia. Nick has been recognized by leading legal directories including Chambers Global and was described by The Legal 500 Europe, Middle East and Africa as "a superb corporate lawyer." Nick has advised clients on complex cross-border transactions around the globe, including advising clients on establishing and investing in new jurisdictions (including China Telecom, TATA, TUI Travel, Sojitz, Hershey, Tabcorp and Global Eagle Entertainment). He has particular interest in the telecoms and technology sectors, including work for Telefónica Spain, O2, China Telecom, and Virgin Connect. Nick’s experience in the financial services and fintech sector covers banks, investment banks, and insurers, including TSB on its separation from Lloyds, Williams & Glyn on its proposed separation from RBS, and some of the largest-ever transactions in the UK insurance market including the merger of Allied Zurich and Zurich Allies to create Zurich Financial Services and the acquisition by Swiss Re of GE's UK business. He has a track record in high-stakes contentious M&A in the emerging markets, including advising Onexim Holdings on its £11 billion split from Interros Holdings and the resulting division of assets and advice to Renaissance Capital and A1 on portfolio acquisitions and special situations across Africa and Eastern Europe. Recent transactions in the life sciences sector include matters for Eli Lilly, 23andMe, and Advanz Pharma.